The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

FHS
June 29, 2023
9:41 am

Researchers performed a phase II randomized clinical trial (RCT).

Yale and Transcend wins US DoD grant for PTSD therapy – Pharmaceutical Technology

Methylone (TSND-201) is a rapid-acting neuroplastogen (a biological substrate not a therapeutic). Image Credit: MargJohnsonVA / Shutterstock. The US Department of Defense has awarded a

September 22, 2023

First-Ever Professional Guidelines for Psychedelic-Assisted Therapy Practitioners Now Published by APPA and BrainFutures | Psychedelic Spotlight

On August 8th, the American Psychedelic Practitioners Association (APPA), which is both the accreditation body for the psychedelic field and the national association for practitioners,

August 8, 2023

Dementia Linked With Depression in Early and Middle Life

Depression diagnosed in early, middle, or late life more than doubled the risk for subsequent dementia, a study of 1.4 million people in Denmark showed.

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.